Chalabi-Dchar, M.; Cruz, E.; Mertani, H.C.; Diaz, J.-J.; Courty, J.; Cascone, I.; Bouvet, P.
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation. Cancers 2021, 13, 4957.
https://doi.org/10.3390/cancers13194957
AMA Style
Chalabi-Dchar M, Cruz E, Mertani HC, Diaz J-J, Courty J, Cascone I, Bouvet P.
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation. Cancers. 2021; 13(19):4957.
https://doi.org/10.3390/cancers13194957
Chicago/Turabian Style
Chalabi-Dchar, Mounira, Elisabeth Cruz, Hichem C. Mertani, Jean-Jacques Diaz, José Courty, Ilaria Cascone, and Philippe Bouvet.
2021. "Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation" Cancers 13, no. 19: 4957.
https://doi.org/10.3390/cancers13194957
APA Style
Chalabi-Dchar, M., Cruz, E., Mertani, H. C., Diaz, J. -J., Courty, J., Cascone, I., & Bouvet, P.
(2021). Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation. Cancers, 13(19), 4957.
https://doi.org/10.3390/cancers13194957